切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2017, Vol. 14 ›› Issue (10) : 743 -748. doi: 10.3877/cma.j.issn.1672-6448.2017.10.006

所属专题: 妇产科超声影像学 乳腺超声 文献

浅表器官超声影像学

超声与正电子发射型计算机断层成像技术在乳腺癌诊断及淋巴结评估中的应用
王红燕1, 靳晓娜1, 姜玉新1,(), 朱朝晖1, 徐颖1, 朱庆莉1, 戴晴1, 李建初1, 李方1   
  1. 1. 100730 中国医学科学院 北京协和医学院 北京协和医院超声医学科
  • 收稿日期:2017-01-01 出版日期:2017-10-01
  • 通信作者: 姜玉新
  • 基金资助:
    国家自然科学基金(81601517,81371557)

Comparison of ultrasound and position emission tomography / computerized tomography in diagnosis and lymph node staging of breast cancer

Hongyan Wang1, Xiaona Jin1, Yuxin Jiang1,(), Zhaohui Zhu1, Ying Xu1, Qingli Zhu1, Qing Dai1, Jianchu Li1, Fang Li1   

  1. 1. Department of Diagnostic Ultrasound, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
  • Received:2017-01-01 Published:2017-10-01
  • Corresponding author: Yuxin Jiang
  • About author:
    Corresponding author: Jiang Yuxin, Email:
引用本文:

王红燕, 靳晓娜, 姜玉新, 朱朝晖, 徐颖, 朱庆莉, 戴晴, 李建初, 李方. 超声与正电子发射型计算机断层成像技术在乳腺癌诊断及淋巴结评估中的应用[J]. 中华医学超声杂志(电子版), 2017, 14(10): 743-748.

Hongyan Wang, Xiaona Jin, Yuxin Jiang, Zhaohui Zhu, Ying Xu, Qingli Zhu, Qing Dai, Jianchu Li, Fang Li. Comparison of ultrasound and position emission tomography / computerized tomography in diagnosis and lymph node staging of breast cancer[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2017, 14(10): 743-748.

目的

比较超声与正电子发射型计算机断层成像(PET/CT)技术在乳腺癌早期诊断中的应用价值。

方法

选取2014年2月至12月在北京协和医院行乳腺病变切除活检术的患者38例,共40个病灶,分别行超声及PET/CT检查,以病理诊断为"金标准"分别统计自动乳腺全容积成像系统(ABVS)及PET/CT的敏感度、特异度、准确性、假阳性、假阴性、阳性及阴性预测值。

结果

超声对乳腺癌诊断的敏感度95.65%、特异度70.59%、准确性85.00%;PET/CT技术对乳腺癌诊断的敏感度86.96%、特异度82.35 %、准确性85.00 %;两者联合应用的诊断敏感度86.96%、特异度94.12%、准确性90.00%。10例乳腺癌淋巴结转移的患者中,PET/CT技术对转移淋巴结诊断的敏感度、特异度及准确性分别为90.0%、92.8%、92.1%,超声对转移淋巴结诊断的敏感度、特异度及准确性分别为70.0%、96.4 %、89.5%。

结论

超声与PET/CT检查对乳腺癌的诊断均为有效的方法。两者联合应用可显著提高诊断的特异度与准确性。PET/CT对淋巴结转移灶敏感度较高,有利于临床分期,对临床治疗方案的选择及患者的预后有重要意义。

Objective

To compare the application of ultrasound and positron emission tomography/computed tomography (PET/CT) in diagnosis and lymph node staging of breast cancer.

Methods

Using automated breast volume scanner (ABVS) and PET/CT examination of 40 lesions in 38 patients, and for comparison with the pathological findings, the diagnostic accuracy of PET/CT and ABVS in breast cancer was comparatively analyzed.

Results

The sensitivity of ABVS in the diagnosis of breast cancer was 95.65%, the specificity was 70.59%, and the accuracy rate was 85.00%; the sensitivity of PET/CT in the diagnosis of breast cancer was 86.96%, the specificity was 82.35%, and the accuracy rate was 85.00%; the diagnostic sensitivity of their combined application was 86.96%, the specificity was 94.12%, and the accuracy rate was 90.00%. In 10 cases of breast cancer patients with lymph node metastasis, the sensitivity、specificity and accuracy rate of PET/CT in the diagnosis of metastatic lymph nodes were 90.0%, 92.8%, and 92.1% respectively; the sensitivity, specificity and accuracy rate of ultrasound in the diagnosis of metastatic lymph nodes were 70.0%, 96.4% and 89.5%, respectively.

Conclusions

The ABVS and PET/CT are both effective approaches in the diagnosis of breast cancer. Their combined application may significantly improve the specificity and accuracy of diagnosis. For patients with lymph node metastases, the sensitivity of PET/CT for lymph node metastases was high and conducive to clinical staging, which is an important implication in guiding the choice of clinical treatment and prognosis of patients.

表1 PET/CT及ABVS对乳腺癌原发灶的诊断价值(%)
图3,4 患者女,63岁,病理为右乳浸润性导管癌(低分化),无淋巴结转移。图3为ABVS右乳外上9~10点见低回声区,大小约2.5 cm,形态不规则,边界不清,回声尚均,超声诊断BI-RADS 5;图4为PET-CT右乳外上象限见一形态不规则且密度欠均匀病灶(箭头所示),大小约2.6 cm,放射性摄取不均匀增高,SUVmax:4.8,病灶内部见放射性减低区
图5 患者女,67岁,病理证实为左乳腺浸润性导管癌。PET-CT示:左乳巨大代谢增高灶,大小,SUV。双侧腋下、纵膈多发肿大淋巴结,代谢明显增高,双侧肋骨、多个脊椎、骨盆多发骨质破坏,代谢增高,均考虑转移灶
[1]
于鹏,王瑞民,徐白萱, 等. 超声乳腺影像报告和数据系统与18F-FDG PET/CT在乳腺疾病诊断中的相关性及联合应用价值 [J]. 中国医学影像学杂志, 2014, (10):730-734.
[2]
朱朝晖. PET /CT在肿瘤学中的应用. 现代仪器 [J]. 2006, (4):16-18.
[3]
Liberman L, Menell JH. Breast imaging reporting and data system (BI-RADS) [J]. Radiol Clin North Am, 2002, 40(3):409-430.
[4]
Greco M, Crippa F, Agresti R, et a1. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management [J]. J Natl Cancer Inst, 2001, 93(8):630-635.
[5]
Kelly KM, Dean J, Comulada WS, et al. Breast cancer detection using automated whole breast ultrasound and mammography in radiographically dense breasts [J]. Eur Radiol, 2010, 20(3):734-742.
[6]
Watermann DO, Foldi M, Hanjalic-Beck A, et al. Three-dimensional ultrasound for the assessment of breast lesions [J]. Ultrasound Obstet Gynecol, 2005, 25(6):592-598.
[7]
Lin X, Wang J, Han F, et al. Analysis of eighty-one cases with breast lesions using automated breast volume scanner and comparison with handheld ultrasound [J]. Eur J Radiol, 2011, doi:10.1016/j.ejrad.2011.02.038
[8]
Wöhrle NK, Hellerhof K, Notohamiprodjo M, et al. Automated breast volume scanner (ABVS). A new approach for breast imaging [J]. Der Onkologe, 2011, doi:10.1007/s00761-011-2040-x [in German].
[9]
Richter K, Heywang-Kobrunner SH, Winzer KJ, et al. Detection of malignant and benign breast lesions with an automated US system: results in 120 cases [J]. Radiology, 1997, 205:823-830.
[10]
Chou YH, Tiu CM, Chen J, et al. Automated full-field breast ultrasonography: the past and the present [J]. J Med Ultrasound, 2007, 15(1):31-44.
[11]
Avril N, Dose J, Jänicke F, et al. Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose [J]. J Clin Oncol, 1996, 14(6):1848-1857.
[12]
Crowe JP Jr, Adler LP, Shenk RR, et al. Positron emission tomography and breast masses: com parison with clinical mammographic, and pathological findings [J]. Ann Surg Oncol, 1994, 1(2):132-140.
[13]
Scheidhauer K, Scharl A, Pietrzyk U, et al. Qualitative 18F-FDG positron emission tomography in primary breast cancer: clinical relevance and practicability [J]. Eur J Nucl Med, 1996, 23(6):618-623.
[14]
Tse NY, Hoh CK, Hawkins RA, et al. The application of positron emission tomograpic imaging with fluorodeoxyglucose to the evaluat on of breast disease [J]. Ann Surg, 1992, 216(1):27-34.
[15]
Buck A, Schirrmeister H, Khn T, et al. FDG uptake in breast cancer: correlation with biologica l and clinical prognostic parameters [J]. Eur J Nucl Med Mol Imaging, 2002, 29(10):1317-1323.
[16]
Heusner TA, Kuemmel S, Hahn S, et al. Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients [J]. Eur J Nucl Med Mol Imaging, 2009, 36(10):1543-1550.
[17]
Inokuchi M, Furukawa H, Kayahara M,et al. The role of 18FDG PET-CT for the initial staging and therapy in primary breast cancer [J]. Gan To Kagaku Ryoho, 2009, 36(13):2526-2531.
[18]
Peare R, Staff RT, Heys SD. The use of FDG-PET in assessing axillary lymph node status in breast cancer: A systematic review and meta-analysis of the literature [J]. Breast Cancer Res Treat, 2010, 123(1):281-290.
[19]
Kim J, Lee J, Chang E, et al. Selective sentinel node plus additional non-sentinel node biopsy based on an FDG-PET/CT scan in early breast cancer patients: Single institutional experience [J]. World J Surg, 2009, 33(5):943.
[20]
Choi YJ, Shin YD, Kang YH, et al. The Effects of Preoperative 18F-FDG PET/CT in Breast Cancer Patients in Comparison to the Conventional Imaging Study [J]. J Breast Cancer, 2012, 15(4):441-448.
[21]
Mahner S, Schirrmacher S, Brenner W, et al. Comparison between positron emission tomography using 2-[fluorine-18] fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer [J]. Ann Oncol, 2008, 19(7):1249-1254.
[1] 魏淑婕, 惠品晶, 丁亚芳, 张白, 颜燕红, 周鹏, 黄亚波. 单侧颈内动脉闭塞患者行颞浅动脉-大脑中动脉搭桥术的脑血流动力学评估[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1046-1055.
[2] 张璇, 马宇童, 苗玉倩, 张云, 吴士文, 党晓楚, 陈颖颖, 钟兆明, 王雪娟, 胡淼, 孙岩峰, 马秀珠, 吕发勤, 寇海燕. 超声对Duchenne肌营养不良儿童膈肌功能的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1068-1073.
[3] 朱连华, 费翔, 韩鹏, 姜波, 李楠, 罗渝昆. 高帧频超声造影在胆囊息肉样病变中的鉴别诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(09): 904-910.
[4] 张梅芳, 谭莹, 朱巧珍, 温昕, 袁鹰, 秦越, 郭洪波, 侯伶秀, 黄文兰, 彭桂艳, 李胜利. 早孕期胎儿头臀长正中矢状切面超声图像的人工智能质控研究[J]. 中华医学超声杂志(电子版), 2023, 20(09): 945-950.
[5] 陈舜, 薛恩生, 叶琴. PDCA在持续改进超声危急值管理制度中的价值[J]. 中华医学超声杂志(电子版), 2023, 20(09): 974-978.
[6] 周钰菡, 肖欢, 唐毅, 杨春江, 周娟, 朱丽容, 徐娟, 牟芳婷. 超声对儿童髋关节暂时性滑膜炎的诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 795-800.
[7] 刘欢颜, 华扬, 贾凌云, 赵新宇, 刘蓓蓓. 颈内动脉闭塞病变管腔结构和血流动力学特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 809-815.
[8] 郏亚平, 曾书娥. 含鳞状细胞癌成分的乳腺化生性癌的超声与病理特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 844-848.
[9] 张丽丽, 陈莉, 余美琴, 聂小艳, 王婧玲, 刘婷. PDCA循环法在超声浅表器官亚专科建设中的应用[J]. 中华医学超声杂志(电子版), 2023, 20(07): 717-721.
[10] 唐玮, 何融泉, 黄素宁. 深度学习在乳腺癌影像诊疗和预后预测中的应用[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 323-328.
[11] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[12] 衣晓丽, 胡沙沙, 张彦. HER-2低表达对乳腺癌新辅助治疗疗效及预后的影响[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 340-346.
[13] 施杰, 李云涛, 高海燕. 腋窝淋巴结阳性Luminal A型乳腺癌患者新辅助与辅助化疗的预后及影响因素分析[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 353-361.
[14] 伍秋苑, 陈佩贤, 邓裕华, 何添成, 周丹. 肠道微生物在乳腺癌中的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 362-365.
[15] 谭巧, 苏小涵, 侯令密, 黎君彦, 邓世山. 乳腺髓样癌的诊治进展[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 366-368.
阅读次数
全文


摘要